Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine.

Suenaga S, Kuramitsu Y, Kaino S, Maehara S, Maehara Y, Sakaida I, Nakamura K.

Anticancer Res. 2014 Jan;34(1):141-6.

PMID:
24403454
2.
3.

Active hexose-correlated compound down-regulates sex-determining region Y-box 2 of pancreatic cancer cells.

Nawata J, Kuramitsu Y, Wang Y, Kitagawa T, Tokuda K, Baron B, Akada J, Suenaga S, Kaino S, Maehara S, Maehara Y, Sakaida I, Nakamura K.

Anticancer Res. 2014 Sep;34(9):4807-11.

PMID:
25202061
4.

CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Cancer Cells.

Kuhara K, Tokuda K, Kitagawa T, Baron B, Tokunaga M, Harada K, Terasaki M, Uehara O, Ohta T, Takai R, Hamada JI, Kobayashi M, Shimo T, Nagayasu H, Kuramitsu Y.

Anticancer Res. 2018 Nov;38(11):6107-6111. doi: 10.21873/anticanres.12961.

PMID:
30396925
5.

KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine.

Taba K, Kuramitsu Y, Ryozawa S, Yoshida K, Tanaka T, Mori-Iwamoto S, Maehara S, Maehara Y, Sakaida I, Nakamura K.

Chemotherapy. 2011;57(1):12-6. doi: 10.1159/000321019. Epub 2010 Dec 3.

PMID:
21124027
6.

Heat-shock protein 27 is phosphorylated in gemcitabine-resistant pancreatic cancer cells.

Taba K, Kuramitsu Y, Ryozawa S, Yoshida K, Tanaka T, Maehara S, Maehara Y, Sakaida I, Nakamura K.

Anticancer Res. 2010 Jul;30(7):2539-43.

PMID:
20682980
7.

Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine.

Mori-Iwamoto S, Kuramitsu Y, Ryozawa S, Mikuria K, Fujimoto M, Maehara S, Maehara Y, Okita K, Nakamura K, Sakaida I.

Int J Oncol. 2007 Dec;31(6):1345-50.

PMID:
17982661
8.

Phosphorylation status of heat shock protein 27 plays a key role in gemcitabine-induced apoptosis of pancreatic cancer cells.

Nakashima M, Adachi S, Yasuda I, Yamauchi T, Kawaguchi J, Itani M, Yoshioka T, Matsushima-Nishiwaki R, Hirose Y, Kozawa O, Moriwaki H.

Cancer Lett. 2011 Dec 27;313(2):218-25. doi: 10.1016/j.canlet.2011.09.008. Epub 2011 Sep 17.

PMID:
21999932
9.

Human pancreatic cancer cells with acquired gemcitabine resistance exhibit significant up-regulation of peroxiredoxin-2 compared to sensitive parental cells.

Suenaga S, Kuramitsu Y, Wang Y, Baron B, Kitagawa T, Akada J, Tokuda K, Kaino S, Maehara S, Maehara Y, Sakaida I, Nakamura K.

Anticancer Res. 2013 Nov;33(11):4821-6.

PMID:
24222118
10.

Up-regulation of DDX39 in human pancreatic cancer cells with acquired gemcitabine resistance compared to gemcitabine-sensitive parental cells.

Kuramitsu Y, Suenaga S, Wang Y, Tokuda K, Kitagawa T, Tanaka T, Akada J, Maehara S, Maehara Y, Nakamura K.

Anticancer Res. 2013 Aug;33(8):3133-6.

PMID:
23898070
11.

Enzyme-treated Asparagus Extract Down-regulates Heat Shock Protein 27 of Pancreatic Cancer Cells.

Shimada T, Nanimoto Y, Baron B, Kitagawa T, Tokuda K, Kuramitsu Y.

In Vivo. 2018 Jul-Aug;32(4):759-763. doi: 10.21873/invivo.11305.

12.

Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells.

Kang D, Choi HJ, Kang S, Kim SY, Hwang YS, Je S, Han Z, Kim JH, Song JJ.

Cell Signal. 2015 Apr;27(4):807-17. doi: 10.1016/j.cellsig.2015.01.007. Epub 2015 Jan 20.

PMID:
25615626
13.

Heat-shock protein 27 plays the key role in gemcitabine-resistance of pancreatic cancer cells.

Kuramitsu Y, Wang Y, Taba K, Suenaga S, Ryozawa S, Kaino S, Sakaida I, Nakamura K.

Anticancer Res. 2012 Jun;32(6):2295-9. Review.

PMID:
22641665
14.

Interferon-gamma down-regulates heat shock protein 27 of pancreatic cancer cells and helps in the cytotoxic effect of gemcitabine.

Mori-Iwamoto S, Taba K, Kuramitsu Y, Ryozawa S, Tanaka T, Maehara S, Maehara Y, Okita K, Nakamura K, Sakaida I.

Pancreas. 2009 Mar;38(2):224-6. doi: 10.1097/MPA.0b013e3181773970. No abstract available.

PMID:
19238023
15.

High-mobility Group Box 1 and Mitogen-activated Protein Kinase activated Protein Kinase-2 Are Up-regulated in Gemcitabine-resistant Pancreatic Cancer Cells.

Kuramitsu Y, Wang Y, Kitagawa T, Tokuda K, Akada J, Tokunaga M, Nakamura K.

Anticancer Res. 2015 Jul;35(7):3861-5.

PMID:
26124331
16.

The flavonoid apigenin potentiates the growth inhibitory effects of gemcitabine and abrogates gemcitabine resistance in human pancreatic cancer cells.

Strouch MJ, Milam BM, Melstrom LG, McGill JJ, Salabat MR, Ujiki MB, Ding XZ, Bentrem DJ.

Pancreas. 2009 May;38(4):409-15. doi: 10.1097/MPA.0b013e318193a074.

PMID:
19142175
17.

Role of heat shock protein 27 in gemcitabine-resistant human pancreatic cancer: comparative proteomic analyses.

Liu QH, Zhao CY, Zhang J, Chen Y, Gao L, Ni CY, Zhu MH.

Mol Med Rep. 2012 Oct;6(4):767-73. doi: 10.3892/mmr.2012.1013. Epub 2012 Jul 31.

PMID:
22858734
18.

Triptolide cooperates with Cisplatin to induce apoptosis in gemcitabine-resistant pancreatic cancer.

Zhu W, Li J, Wu S, Li S, Le L, Su X, Qiu P, Hu H, Yan G.

Pancreas. 2012 Oct;41(7):1029-38. doi: 10.1097/MPA.0b013e31824abdc0.

PMID:
22617708
19.

pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression.

Wang M, Lu X, Dong X, Hao F, Liu Z, Ni G, Chen D.

World J Surg Oncol. 2015 Feb 21;13:66. doi: 10.1186/s12957-015-0451-7.

20.

Mechanisms underlying gemcitabine resistance in pancreatic cancer and sensitisation by the iMiDâ„¢ lenalidomide.

Fryer RA, Barlett B, Galustian C, Dalgleish AG.

Anticancer Res. 2011 Nov;31(11):3747-56.

PMID:
22110196

Supplemental Content

Support Center